<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9">
 <label>9.</label>
 <mixed-citation publication-type="webpage">
  <person-group person-group-type="author">
   <collab>European Medicines Agency (EMA)</collab>
  </person-group>
  <article-title>Appendix IV of the Guideline on the Investigation on Bioequivalence (CPMP/EWP/QWP/1401/98 Rev.1): Presentation of Biopharmaceutical and Bioanalytical Data in Module 2.7.1</article-title>. (
  <year>2011</year>). Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/documents/scientific-guideline/appendix-iv-guideline-investigation-bioequivalence-cpmp/ewp/qwp/1401/98-rev1-presentation-biopharmaceutical-bioanalytical-data-module-271_en.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ema.europa.eu/en/documents/scientific-guideline/appendix-iv-guideline-investigation-bioequivalence-cpmp/ewp/qwp/1401/98-rev1-presentation-biopharmaceutical-bioanalytical-data-module-271_en.pdf</ext-link>.
 </mixed-citation>
</ref>
